{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:33:46Z","timestamp":1762223626326,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["509164523031"],"award-info":[{"award-number":["509164523031"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515013270"],"award-info":[{"award-number":["2024A1515013270"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["201704020146"],"award-info":[{"award-number":["201704020146"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.109013","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:51:20Z","timestamp":1758613880000},"page":"109013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, anti-acute ischemic stroke (AIS) effect of receptor-interacting protein kinase 1 (RIPK1) inhibitors containing quinazoline structure"],"prefix":"10.1016","volume":"165","author":[{"given":"Ruiqi","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingning","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingdi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongyun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueshi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bioorg.2025.109013_bb0005","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3390\/antiox11112201","article-title":"Microglial dysfunction in neurodegenerative diseases via RIPK1 and ROS","volume":"11","author":"Wu","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109013_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11064-023-04013-8","article-title":"Necrostatin-1s suppresses RIPK1-driven necroptosis and inflammation in periventricular leukomalacia neonatal mice","volume":"49","author":"Sun","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2025.109013_bb0015","series-title":"Advances in RIPK1 kinase inhibitors","volume":"13","author":"Chen","year":"2022"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109013_bb0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41401-023-01069-8","article-title":"RIPK1 inhibition contributes to lysosomal membrane stabilization in ischemic astrocytes via a lysosomal Hsp70.1B-dependent mechanism","volume":"44","author":"Du","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109013_bb0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219091120","article-title":"Myeloid-derived MIF drives RIPK1-mediated cerebromicrovascular endothelial cell death to exacerbate ischemic brain injury","volume":"120","author":"Li","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109013_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tips.2020.01.002","article-title":"Inhibitors targeting RIPK1\/RIPK3: old and new drugs","volume":"41","author":"Martens","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109013_bb0035","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/acs.jmedchem.7b01449","article-title":"Tozasertib analogues as inhibitors of necroptotic cell death","volume":"61","author":"Hofmans","year":"2018","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109013_bb0040","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/ml400382p","article-title":"Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis","volume":"4","author":"Harris","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109013_bb0045","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1021\/acs.jmedchem.8b01652","article-title":"Identification of 5-(2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as a new class of receptor-interacting protein kinase 1 (RIPK1) inhibitors, which showed potent activity in a tumor metastasis model","volume":"61","author":"Li","year":"2018","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109013_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.176","article-title":"Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models","volume":"3","author":"Takahashi","year":"2012","journal-title":"Cell Death Dis."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109013_bb0055","doi-asserted-by":"crossref","first-page":"14957","DOI":"10.1021\/acs.jmedchem.2c01478","article-title":"Discovery of a trifluoromethoxy cyclopentanone benzothiazole receptor-interacting protein kinase 1 inhibitor as the treatment for Alzheimer\u2019s disease","volume":"65","author":"Sun","year":"2022","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109013_bb0060","doi-asserted-by":"crossref","first-page":"15288","DOI":"10.1021\/acs.jmedchem.3c01351","article-title":"Insight from linker investigations: discovery of a novel phenylbenzothiazole necroptosis inhibitor targeting receptor-interacting protein kinase 1 (RIPK1) from a phenoxybenzothiazole compound with dual RIPK1\/3 targeting activity","volume":"66","author":"Fang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109013_bb0065","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1021\/acs.jmedchem.3c00197","article-title":"Targeting receptor-interacting protein kinase 1 by novel benzothiazole derivatives: treatment of acute lung injury through the necroptosis pathway","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109013_bb0070","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1038\/s41467-022-34692-w","article-title":"Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109013_bb0075","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2018.03.076","article-title":"An overview of quinazolines: pharmacological significance and recent developments","volume":"151","author":"Alagarsamy","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109013_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112640","article-title":"Novel quinazoline-based EGFR kinase inhibitors: a review focusing on SAR and molecular docking studies (2015-2019)","volume":"204","author":"Bhatia","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109013_bb0085","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1021\/acs.jmedchem.1c01968","article-title":"Structure-guided discovery of aminoquinazolines as brain-penetrant and selective LRRK2 inhibitors","volume":"65","author":"Keylor","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109013_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.109013_bb0095","first-page":"103","article-title":"Necroptosis: Mechanisms and Relevance to Disease","volume":"12","author":"Galluzzi","year":"2017"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109013_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"null","key":"10.1016\/j.bioorg.2025.109013_bb0105","first-page":"3445","article-title":"Animal models of ischemic stroke and their application in clinical research","volume":"9","author":"Fluri","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2025.109013_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107299","article-title":"Edaravone for acute ischemic stroke \u2013 systematic review with meta-analysis","volume":"219","author":"Fidalgo","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"year":"1988","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Jacob","key":"10.1016\/j.bioorg.2025.109013_bb0115"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109013_bb0120","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"Superior to the HERG model in predicting torsade de pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Sci. Rep."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:31:56Z","timestamp":1762223516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"alternative-id":["S0045206825008934"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109013","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, anti-acute ischemic stroke (AIS) effect of receptor-interacting protein kinase 1 (RIPK1) inhibitors containing quinazoline structure","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109013"}}